HKT288 in Solid Tumors, Including Epithelial Ovarian Cancer and Renal Cell Carcinoma
Clinical trial NCT02947152 · TERMINATED
Trial details
- NCT number
- NCT02947152
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-01
- Primary completion
- 2017-09-14
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.